EX-23.1 2 d415240dex231.htm CONSENT OF KPMG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Consent of KPMG LLP, Independent Registered Public Accounting Firm

Exhibit 23.1

The Board of Directors

Cumberland Pharmaceuticals Inc.:

We consent to the use of our reports with respect to the consolidated financial statements and schedule and the effectiveness of internal control over financial reporting incorporated by reference herein and to the reference to our firm under the heading “Experts” in the prospectus.

/s/ KPMG LLP

Nashville, Tennessee

October 26, 2012